657 studies found for:    osteoporosis AND (woman OR women OR female)
Show Display Options
Rank Status Study
21 Terminated A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.
Condition: Osteoporosis
Interventions: Drug: Ronacaleret;   Drug: Teriparatide;   Drug: Alendronate
22 Completed STEP: Study of Imaging Techniques (ImaTx and DXA) in Postmenopausal Women With OstEoporosis Using Preotact (FP-008-ES)
Condition: Postmenopausal Women With Primary Osteoporosis
Intervention: Drug: Parathyroid hormone (PTH)
23 Completed
Has Results
Effect of Full Length Parathyroid Hormone, PTH(1-84) or Strontium Ranelate on Bone Markers in Postmenopausal Women With Primary Osteoporosis (FP-006-IM)
Condition: Osteoporosis
Interventions: Drug: Full Length Parathyroid Hormone, PTH(1-84);   Drug: Strontium Ranelate
24 Unknown  Recognizing Osteoporosis and Its Consequences in Quebec (ROCQ) Programme
Condition: Osteoporosis
Interventions: Behavioral: Control Group;   Behavioral: Written documentation on osteoporosis group;   Behavioral: Written documentation on osteoporosis and video group
25 Completed
Has Results
Foot Orthoses and Elderly Women With Osteoporosis
Condition: Osteoporosis
Intervention: Device: Foot orthosis (Orthotics Unit of the Clinical Hospital of UNICAMP)
26 Completed Osteoporosis Choice Decision Aid for Use of Bisphosphonates in Postmenopausal Women
Conditions: Osteoporosis;   Bone Loss, Age Related;   Postmenopausal Bone Loss;   Postmenopausal Osteoporosis
Intervention: Behavioral: Osteoporosis Choice Decision Aid
27 Enrolling by invitation Point-of-care Osteoporosis Diagnostics With Bindex® Pocket Size Instrument and FRAX
Condition: Osteoporosis
Intervention:
28 Completed PTH Comparison in Post Menopausal Women
Condition: Osteoporosis, Post-Menopausal
Interventions: Drug: teriparatide 20 micrograms/day subcutaneous;   Drug: calcitonin 100 IU/day subcutaneous
29 Completed Dose Ranging Study - Macroflux PTH in Postmenopausal Women With Osteoporosis
Condition: Osteoporosis
Intervention: Drug: teriparatide
30 Completed Study of PH3 for the Prevention of Osteoporosis in Postmenopausal Women
Condition: Osteoporosis
Intervention: Drug: PH3
31 Completed
Has Results
Melatonin Osteoporosis Prevention Study
Conditions: Osteoporosis;   Osteopenia
Interventions: Dietary Supplement: melatonin;   Dietary Supplement: sugar pill
32 Active, not recruiting Teriparatide (PTH) and Bone Strength in Postmenopausal Women
Condition: Osteoporosis
Intervention: Drug: Forteo
33 Completed
Has Results
A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab
Conditions: Low Bone Mass;   Low Bone Mineral Density;   Osteoporosis;   Postmenopausal Osteoporosis
Intervention: Drug: Previous denosumab
34 Completed A Study of Arzoxifene to Treat Korean Women With Osteoporosis
Condition: Osteoporosis
Interventions: Drug: arzoxifene;   Drug: Placebo
35 Unknown  Phase III Clinical Trial of DP-R206 and Bonvia In Postmenopausal Women With Osteoporosis
Condition: Postmenopausal Women With Osteoporosis
Interventions: Drug: Test group;   Drug: Reference group
36 Completed Efficacy & Safety of ViaDerm-hPTH(1-34) Compared to Forteo SC in Postmenopausal Women With Osteoporosis
Condition: Osteoporosis
Intervention: Drug: Teriparatide
37 Completed Safety and Efficacy of AAE581 in Postmenopausal Women With Osteoporosis
Condition: Osteoporosis
Intervention: Drug: AAE581
38 Completed Drug Holidays in the Treatment With Alendronate in Postmenopausal Women With Osteoporosis
Condition: Osteoporosis
Intervention: Drug: alendronate
39 Terminated Low-Dose Hormone Replacement Therapy and Alendronate for Osteoporosis
Conditions: Osteopenia;   Osteoporosis
Interventions: Drug: Alendronate;   Drug: Estrogen/progestin therapy
40 Completed
Has Results
A Study to Test the Effect of MK0217A on Vitamin D Inadequacy in Postmenopausal Women With Osteoporosis (0217A-262)
Condition: Osteoporosis
Interventions: Drug: FOSAVANCE 5600 (Alendronate Sodium (+) cholecalciferol);   Dietary Supplement: Calcium Supplement 500 mg;   Other: Referred-Care Model

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years